癌薬の開発におけるニューラルコンピューティング:作用のメカニズムを予測する

J N Weinstein¹, K W Kohn, M R Grever

¹Laboratory of Mathematical Biology, National Cancer Institute, Bethesda, MD 20892.

Science (New York, N.Y.)

|October 16, 1992

まとめ

神経ネットワークは,細胞線活動パターンから抗がん薬の作用機構を正確に予測します. このコンピューティングによるアプローチは,新しい治療薬の分類を改善することによって,薬剤発見を強化します.

科学分野:

計算生物学とは,計算生物学である.
薬理学薬理学とは
薬剤開発における人工知能

背景:

国立がん研究所 (National Cancer Institute) の薬物スクリーニングプログラムは,多数の抗がん剤をテストしています.
薬剤の作用メカニズムを予測することは,その開発パイプラインにとって極めて重要です.
伝統的な統計的手法には,複雑な生物学的データを分析する際の限界があります.

研究の目的:

薬剤の作用メカニズムを予測するためのニューラルネットワークの開発と評価.
標準的な統計技術と比較してニューラルネットワークの有効性を評価する.
抗がん薬の発見を加速させるためのAIの潜在能力を探求する.

主な方法:

ニューラルネットワークを利用して,60の悪性細胞系における薬物活性パターンを分析する.
神経ネットワークのパフォーマンスを線形差別分析と比較する.
抗がん剤のデータセットに予測モデルを訓練し,適用する.

主要な成果:

神経ネットワークは,薬物作用機構の誤分類率8.5%を達成しました.
線形差別分析の結果,誤った分類率は14.2%であった.
細胞線活動パターンは,薬物メカニズムに関する重要な情報を含んでいます.

結論:

神経ネットワークは,薬物メカニズムを予測するために,細胞線応答データを効果的に活用します.
このAI駆動のアプローチは,年間1万以上のエージェントを将来的に分類することができます.
AIと統計的ツールは,抗がん剤のインビトロから臨床試験への移行を簡素化することができます.

さらに関連する動画

08:23

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

Published on: April 12, 2016

10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

関連する概念動画

02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

02:53

Adaptive Mechanisms in Cancer Cells

01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...

関連する実験動画